Interpersonal Values of Patients Participating in Phase II –III Clinical Trials: Implications for Clinical Trial Representativeness
ConclusionsThis novel analysis of the interpersonal values of patients that participate in Phase II and III clinical trials revealed that the patients ’ interpersonal values largely differed from those of the Portuguese normative population. Better understanding the implications of these findings for clinical trial representativeness and outcomes is of crucial importance.
Source: Pharmaceutical Medicine - Category: Drugs & Pharmacology Source Type: research
More News: Alcoholism | Arthritis | Cancer | Cancer & Oncology | Cardiology | Clinical Trials | Drugs & Pharmacology | Heart | Heart Attack | Heart Failure | Lung Cancer | Multiple Sclerosis | Portugal Health | Psychology | Rheumatoid Arthritis | Rheumatology | Stroke | Study